{"entity":{"type":"insider","cik":"0001652901","url":"/insider/0001652901","json_url":"/insider/0001652901.json","name":"Avalon Ventures XI, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":49,"n_filings":7,"first":"2021-06-16","last":"2024-10-18","span_basis":"filed_date"},"name_variants":[{"name":"Avalon Ventures XI, L.P.","source":"filing","n_filings":7,"first_seen":"2021-06-16","last_seen":"2024-10-18"}],"transactions":[{"id":2070759,"accession":"0001415889-24-025436","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-25","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":553219.0,"shares_display":"553,219","price_per_share":44.75,"price_display":"44.75","price_state":"stated","total_value":24756550.25,"total_display":"24,756,550.25","shares_owned_after":2115373.0,"shares_owned_after_display":"2,115,373","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-18","scope":"insider"},{"id":2070757,"accession":"0001415889-24-025436","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-24","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":541824.0,"shares_display":"541,824","price_per_share":44.75,"price_display":"44.75","price_state":"stated","total_value":24246624.0,"total_display":"24,246,624.00","shares_owned_after":2071799.0,"shares_owned_after_display":"2,071,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-18","scope":"insider"},{"id":2070755,"accession":"0001415889-24-025436","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-23","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104957.0,"shares_display":"104,957","price_per_share":44.75,"price_display":"44.75","price_state":"stated","total_value":4696825.75,"total_display":"4,696,825.75","shares_owned_after":401321.0,"shares_owned_after_display":"401,321","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-18","scope":"insider"},{"id":2070754,"accession":"0001415889-24-025436","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-22","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104892.0,"shares_display":"104,892","price_per_share":50.3,"price_display":"50.30","price_state":"stated","total_value":5276067.6,"total_display":"5,276,067.60","shares_owned_after":2684380.0,"shares_owned_after_display":"2,684,380","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-18","scope":"insider"},{"id":2070752,"accession":"0001415889-24-025436","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-21","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102732.0,"shares_display":"102,732","price_per_share":50.3,"price_display":"50.30","price_state":"stated","total_value":5167419.6,"total_display":"5,167,419.60","shares_owned_after":2629085.0,"shares_owned_after_display":"2,629,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-18","scope":"insider"},{"id":2070750,"accession":"0001415889-24-025436","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-20","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19900.0,"shares_display":"19,900","price_per_share":50.3,"price_display":"50.30","price_state":"stated","total_value":1000970.0,"total_display":"1,000,970.00","shares_owned_after":509273.0,"shares_owned_after_display":"509,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-18","scope":"insider"},{"id":2070748,"accession":"0001415889-24-025436","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-19","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15788.0,"shares_display":"15,788","price_per_share":51.18,"price_display":"51.18","price_state":"stated","total_value":808029.84,"total_display":"808,029.84","shares_owned_after":2668592.0,"shares_owned_after_display":"2,668,592","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-18","scope":"insider"},{"id":2070746,"accession":"0001415889-24-025436","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-18","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15462.0,"shares_display":"15,462","price_per_share":51.18,"price_display":"51.18","price_state":"stated","total_value":791345.16,"total_display":"791,345.16","shares_owned_after":2613623.0,"shares_owned_after_display":"2,613,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-18","scope":"insider"},{"id":2070744,"accession":"0001415889-24-025436","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-17","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2995.0,"shares_display":"2,995","price_per_share":51.18,"price_display":"51.18","price_state":"stated","total_value":153284.1,"total_display":"153,284.10","shares_owned_after":506278.0,"shares_owned_after_display":"506,278","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-18","scope":"insider"},{"id":2070741,"accession":"0001415889-24-025436","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-16","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1843.0,"shares_display":"1,843","price_per_share":50.02,"price_display":"50.02","price_state":"stated","total_value":92186.86,"total_display":"92,186.86","shares_owned_after":6371.0,"shares_owned_after_display":"6,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-17","filed_date":"2024-10-18","scope":"insider"},{"id":2070729,"accession":"0001415889-24-025436","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-11","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61445.0,"shares_display":"61,445","price_per_share":49.69,"price_display":"49.69","price_state":"stated","total_value":3053202.05,"total_display":"3,053,202.05","shares_owned_after":2819366.0,"shares_owned_after_display":"2,819,366","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider"},{"id":2070726,"accession":"0001415889-24-025436","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-10","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60179.0,"shares_display":"60,179","price_per_share":49.69,"price_display":"49.69","price_state":"stated","total_value":2990294.51,"total_display":"2,990,294.51","shares_owned_after":2761291.0,"shares_owned_after_display":"2,761,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider"},{"id":2070722,"accession":"0001415889-24-025436","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-9","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30094.0,"shares_display":"30,094","price_per_share":50.61,"price_display":"50.61","price_state":"stated","total_value":1523057.34,"total_display":"1,523,057.34","shares_owned_after":2789272.0,"shares_owned_after_display":"2,789,272","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider"},{"id":2070719,"accession":"0001415889-24-025436","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-8","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29474.0,"shares_display":"29,474","price_per_share":50.61,"price_display":"50.61","price_state":"stated","total_value":1491679.14,"total_display":"1,491,679.14","shares_owned_after":2731817.0,"shares_owned_after_display":"2,731,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider"},{"id":2070717,"accession":"0001415889-24-025436","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-7","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11657.0,"shares_display":"11,657","price_per_share":49.69,"price_display":"49.69","price_state":"stated","total_value":579236.33,"total_display":"579,236.33","shares_owned_after":534883.0,"shares_owned_after_display":"534,883","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider"},{"id":2070715,"accession":"0001415889-24-025436","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-6","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10957.0,"shares_display":"10,957","price_per_share":50.8,"price_display":"50.80","price_state":"stated","total_value":556615.6,"total_display":"556,615.60","shares_owned_after":6445.0,"shares_owned_after_display":"6,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider"},{"id":2070710,"accession":"0001415889-24-025436","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-5","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5710.0,"shares_display":"5,710","price_per_share":50.61,"price_display":"50.61","price_state":"stated","total_value":288983.1,"total_display":"288,983.10","shares_owned_after":529173.0,"shares_owned_after_display":"529,173","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider"},{"id":3178471,"accession":"0001415889-24-024119","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-22","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":958.0,"shares_display":"958","price_per_share":46.24,"price_display":"46.24","price_state":"stated","total_value":44297.92,"total_display":"44,297.92","shares_owned_after":6887.0,"shares_owned_after_display":"6,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-30","filed_date":"2024-09-30","scope":"insider"},{"id":3178424,"accession":"0001415889-24-024119","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-17","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46861.0,"shares_display":"46,861","price_per_share":46.42,"price_display":"46.42","price_state":"stated","total_value":2175287.62,"total_display":"2,175,287.62","shares_owned_after":2882353.0,"shares_owned_after_display":"2,882,353","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-09-30","scope":"insider"},{"id":3178414,"accession":"0001415889-24-024119","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-16","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45894.0,"shares_display":"45,894","price_per_share":46.42,"price_display":"46.42","price_state":"stated","total_value":2130399.48,"total_display":"2,130,399.48","shares_owned_after":2822981.0,"shares_owned_after_display":"2,822,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-09-30","scope":"insider"},{"id":3178410,"accession":"0001415889-24-024119","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-15","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8894.0,"shares_display":"8,894","price_per_share":46.42,"price_display":"46.42","price_state":"stated","total_value":412859.48,"total_display":"412,859.48","shares_owned_after":546833.0,"shares_owned_after_display":"546,833","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-09-30","scope":"insider"},{"id":3178405,"accession":"0001415889-24-024119","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-14","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1826.0,"shares_display":"1,826","price_per_share":46.19,"price_display":"46.19","price_state":"stated","total_value":84342.94,"total_display":"84,342.94","shares_owned_after":6926.0,"shares_owned_after_display":"6,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-09-30","scope":"insider"},{"id":3178399,"accession":"0001415889-24-024119","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-13","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1542.0,"shares_display":"1,542","price_per_share":47.74,"price_display":"47.74","price_state":"stated","total_value":73615.08,"total_display":"73,615.08","shares_owned_after":2880811.0,"shares_owned_after_display":"2,880,811","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-09-30","scope":"insider"},{"id":3178392,"accession":"0001415889-24-024119","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-12","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1511.0,"shares_display":"1,511","price_per_share":47.74,"price_display":"47.74","price_state":"stated","total_value":72135.14,"total_display":"72,135.14","shares_owned_after":2821470.0,"shares_owned_after_display":"2,821,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-09-30","scope":"insider"},{"id":3178387,"accession":"0001415889-24-024119","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-11","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":293.0,"shares_display":"293","price_per_share":47.74,"price_display":"47.74","price_state":"stated","total_value":13987.82,"total_display":"13,987.82","shares_owned_after":546540.0,"shares_owned_after_display":"546,540","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-09-30","scope":"insider"},{"id":3178362,"accession":"0001415889-24-024119","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-6","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50539.0,"shares_display":"50,539","price_per_share":46.78,"price_display":"46.78","price_state":"stated","total_value":2364214.42,"total_display":"2,364,214.42","shares_owned_after":2970875.0,"shares_owned_after_display":"2,970,875","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-26","filed_date":"2024-09-30","scope":"insider"},{"id":3178357,"accession":"0001415889-24-024119","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-5","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49497.0,"shares_display":"49,497","price_per_share":46.78,"price_display":"46.78","price_state":"stated","total_value":2315469.66,"total_display":"2,315,469.66","shares_owned_after":2909678.0,"shares_owned_after_display":"2,909,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-26","filed_date":"2024-09-30","scope":"insider"},{"id":3178352,"accession":"0001415889-24-024119","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-4","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41661.0,"shares_display":"41,661","price_per_share":47.77,"price_display":"47.77","price_state":"stated","total_value":1990145.97,"total_display":"1,990,145.97","shares_owned_after":2929214.0,"shares_owned_after_display":"2,929,214","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-26","filed_date":"2024-09-30","scope":"insider"},{"id":3178348,"accession":"0001415889-24-024119","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-3","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40803.0,"shares_display":"40,803","price_per_share":47.77,"price_display":"47.77","price_state":"stated","total_value":1949159.31,"total_display":"1,949,159.31","shares_owned_after":2868875.0,"shares_owned_after_display":"2,868,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-26","filed_date":"2024-09-30","scope":"insider"},{"id":3178343,"accession":"0001415889-24-024119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-2","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9592.0,"shares_display":"9,592","price_per_share":46.78,"price_display":"46.78","price_state":"stated","total_value":448713.76,"total_display":"448,713.76","shares_owned_after":563635.0,"shares_owned_after_display":"563,635","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-26","filed_date":"2024-09-30","scope":"insider"},{"id":3178337,"accession":"0001415889-24-024119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-1","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7908.0,"shares_display":"7,908","price_per_share":47.77,"price_display":"47.77","price_state":"stated","total_value":377765.16,"total_display":"377,765.16","shares_owned_after":555727.0,"shares_owned_after_display":"555,727","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-26","filed_date":"2024-09-30","scope":"insider"},{"id":2756550,"accession":"0001415889-24-023337","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001415889-24-023337","line_url":"/filing/0001415889-24-023337#line-9","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":161356.0,"shares_display":"161,356","price_per_share":47.0,"price_display":"47.00","price_state":"stated","total_value":7583732.0,"total_display":"7,583,732.00","shares_owned_after":3021414.0,"shares_owned_after_display":"3,021,414","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-12","scope":"insider"},{"id":2756545,"accession":"0001415889-24-023337","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-24-023337","line_url":"/filing/0001415889-24-023337#line-8","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":158031.0,"shares_display":"158,031","price_per_share":47.0,"price_display":"47.00","price_state":"stated","total_value":7427457.0,"total_display":"7,427,457.00","shares_owned_after":2959175.0,"shares_owned_after_display":"2,959,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-12","scope":"insider"},{"id":2756540,"accession":"0001415889-24-023337","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-24-023337","line_url":"/filing/0001415889-24-023337#line-7","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30613.0,"shares_display":"30,613","price_per_share":47.0,"price_display":"47.00","price_state":"stated","total_value":1438811.0,"total_display":"1,438,811.00","shares_owned_after":573227.0,"shares_owned_after_display":"573,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-12","scope":"insider"},{"id":2756535,"accession":"0001415889-24-023337","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-023337","line_url":"/filing/0001415889-24-023337#line-6","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35047.0,"shares_display":"35,047","price_per_share":46.66,"price_display":"46.66","price_state":"stated","total_value":1635293.02,"total_display":"1,635,293.02","shares_owned_after":3182770.0,"shares_owned_after_display":"3,182,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":2756532,"accession":"0001415889-24-023337","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-023337","line_url":"/filing/0001415889-24-023337#line-5","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34326.0,"shares_display":"34,326","price_per_share":46.66,"price_display":"46.66","price_state":"stated","total_value":1601651.16,"total_display":"1,601,651.16","shares_owned_after":3117206.0,"shares_owned_after_display":"3,117,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":2756530,"accession":"0001415889-24-023337","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-023337","line_url":"/filing/0001415889-24-023337#line-4","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11557.0,"shares_display":"11,557","price_per_share":46.13,"price_display":"46.13","price_state":"stated","total_value":533124.41,"total_display":"533,124.41","shares_owned_after":3217817.0,"shares_owned_after_display":"3,217,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":2756525,"accession":"0001415889-24-023337","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-023337","line_url":"/filing/0001415889-24-023337#line-3","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11319.0,"shares_display":"11,319","price_per_share":46.13,"price_display":"46.13","price_state":"stated","total_value":522145.47,"total_display":"522,145.47","shares_owned_after":3151532.0,"shares_owned_after_display":"3,151,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":2756521,"accession":"0001415889-24-023337","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023337","line_url":"/filing/0001415889-24-023337#line-2","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6649.0,"shares_display":"6,649","price_per_share":46.66,"price_display":"46.66","price_state":"stated","total_value":310242.34,"total_display":"310,242.34","shares_owned_after":603840.0,"shares_owned_after_display":"603,840","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":2756517,"accession":"0001415889-24-023337","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-023337","line_url":"/filing/0001415889-24-023337#line-1","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2193.0,"shares_display":"2,193","price_per_share":46.13,"price_display":"46.13","price_state":"stated","total_value":101163.09,"total_display":"101,163.09","shares_owned_after":610489.0,"shares_owned_after_display":"610,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":2900574,"accession":"0001415889-24-023153","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-24-023153","line_url":"/filing/0001415889-24-023153#line-8","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2182.0,"shares_display":"2,182","price_per_share":42.33,"price_display":"42.33","price_state":"stated","total_value":92364.06,"total_display":"92,364.06","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-10","scope":"insider"},{"id":2900559,"accession":"0001415889-24-023153","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-023153","line_url":"/filing/0001415889-24-023153#line-3","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110644.0,"shares_display":"110,644","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":4647048.0,"total_display":"4,647,048.00","shares_owned_after":3229374.0,"shares_owned_after_display":"3,229,374","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-06","filed_date":"2024-09-10","scope":"insider"},{"id":2900556,"accession":"0001415889-24-023153","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023153","line_url":"/filing/0001415889-24-023153#line-2","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108365.0,"shares_display":"108,365","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":4551330.0,"total_display":"4,551,330.00","shares_owned_after":3162851.0,"shares_owned_after_display":"3,162,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-06","filed_date":"2024-09-10","scope":"insider"},{"id":2900553,"accession":"0001415889-24-023153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-023153","line_url":"/filing/0001415889-24-023153#line-1","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20991.0,"shares_display":"20,991","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":881622.0,"total_display":"881,622.00","shares_owned_after":612682.0,"shares_owned_after_display":"612,682","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-06","filed_date":"2024-09-10","scope":"insider"},{"id":2999966,"accession":"0001415889-24-015673","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-015673","line_url":"/filing/0001415889-24-015673#line-3","is_derivative":false,"issuer_cik":"0001652901","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001652901","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":691525.0,"shares_display":"691,525","price_per_share":54.75,"price_display":"54.75","price_state":"stated","total_value":37860993.75,"total_display":"37,860,993.75","shares_owned_after":3340018.0,"shares_owned_after_display":"3,340,018","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"},{"id":2999961,"accession":"0001415889-24-015673","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-015673","line_url":"/filing/0001415889-24-015673#line-2","is_derivative":false,"issuer_cik":"0001652901","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001652901","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":677279.0,"shares_display":"677,279","price_per_share":54.75,"price_display":"54.75","price_state":"stated","total_value":37081025.25,"total_display":"37,081,025.25","shares_owned_after":3271216.0,"shares_owned_after_display":"3,271,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"},{"id":2999956,"accession":"0001415889-24-015673","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-015673","line_url":"/filing/0001415889-24-015673#line-1","is_derivative":false,"issuer_cik":"0001652901","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001652901","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131196.0,"shares_display":"131,196","price_per_share":54.75,"price_display":"54.75","price_state":"stated","total_value":7182981.0,"total_display":"7,182,981.00","shares_owned_after":633673.0,"shares_owned_after_display":"633,673","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"},{"id":8727204,"accession":"0001209191-23-055083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-055083","line_url":"/filing/0001209191-23-055083#line-1","is_derivative":false,"issuer_cik":"0001652901","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001652901","owner_cik":null,"owner_name":"Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.; Avalon Ventures XI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":849854.0,"shares_display":"849,854","price_per_share":5.87,"price_display":"5.87","price_state":"stated","total_value":4988642.98,"total_display":"4,988,642.98","shares_owned_after":849854.0,"shares_owned_after_display":"849,854","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-13","filed_date":"2023-11-13","scope":"insider"},{"id":5529283,"accession":"0001209191-21-041032","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-041032","line_url":"/filing/0001209191-21-041032#line-6","is_derivative":false,"issuer_cik":"0001652901","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001652901","owner_cik":null,"owner_name":"Avalon Ventures XI, L.P.; Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":629411.0,"shares_display":"629,411","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":10699987.0,"total_display":"10,699,987.00","shares_owned_after":4479492.0,"shares_owned_after_display":"4,479,492","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-16","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001817713","name":"Janux Therapeutics, Inc.","url":"/issuer/0001817713","role":"Ten percent owner","n_filings":7,"first_seen":"2021-06-16","last_seen":"2024-10-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001652901","retrieved_at":"2026-08-21T08:08:03+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}